MGI Tech Unveils Next-Generation Automation Portfolio at SLAS Europe 2025 in Germany
HAMBURG, Germany, May 21, 2025 /PRNewswire/ -- MGI Tech Co., Ltd. (MGI), a company dedicated to developing core tools and technologies that drive innovation in life sciences, is proud to unveil its latest innovation, PrepALL, a flexible liquid handling system, along with the latest version of the Smart8 at SLAS Europe 2025, taking place from May 20–22 in Hamburg. Featuring advanced robotics, AI integration, and modular platforms, MGI's automation portfolio addresses critical challenges in genomics, drug discovery, synthetic biology, and molecular diagnostics—empowering labs of all sizes to scale research efficiently.
PrepALL: Compact, Affordable Automation for Flexible Pipetting
The PrepALL Flexible Liquid Handling Platform simplifies complex laboratory tasks while maintaining enterprise-level performance—without the high costs typically associated with traditional systems. Compact yet powerful, PrepALL is ideal for laboratories adopting automation for the first time or scaling existing research capacity.
Key Features Include:
- Space-saving design: Occupies just 0.7 m², with 16 SBS deck positions (expandable to 41).
- High-precision pipetting: 8 independent channels support 0.5–1200 µL volumes with CVs (coefficients of variation) of less than 3% (1–50 µL) and <1% (50–1200 µL). It supports pLLD/cLLD, liquid level tracking, and anti-dripping, so that it reduces dead volume and improves pipetting accuracy.
- Plug-and-play setup and easy to use: Integrated with a visual system, it can achieve automatic consumables identification and automatic position calibration
- Full traceability: Built-in sensors and data logging ensure reproducibility and consistency.
Leveraging advanced vision-based AI, PrepALL delivers high-precision performance in critical applications such as nucleic acid extraction, plasmid construction, sample preparation, and NGS library prep. Designed for global accessibility, it addresses cost and complexity barriers with a scalable, modular design and open APIs. Ideal for both entry-level and high-throughput environments, PrepALL empowers smaller labs to scale without costly infrastructure overhauls.
"PrepALL represents a major leap in lab automation, giving labs of all sizes the ability to streamline complex workflows with unmatched affordability and reliability. It's a bold step in our mission to democratize cutting-edge tools and accelerate scientific discovery worldwide." said Dr. Christian Zimmerman, VP of Sales at MGI Europe and Africa.
Scalable Automation Ecosystem for Every Lab
MGI's automation portfolio is among the most versatile in the industry, designed to meet diverse laboratory needs while ensuring scalability and ease of use. At SLAS Europe 2025, MGI also presents Smart 8, a globally recognized solution launched in 2022. Smart 8 features eight-channel pipetting, and smart gripper technology. The new enhancement introduces AI-optimized pipetting for up to 20% faster cycle times, including nucleic acid extraction, microbial screening, and library preparation. This update ensures higher reproducibility and efficiency, making the Smart 8 an ideal partner for labs seeking reliable automation while remaining cost-effective.
The enhanced capabilities of the Smart 8 will cater to academic institutions, biotech startups, and clinical labs, offering a competitive edge in high-throughput research. By reducing manual intervention, the system accelerates time-to-results, enabling researchers to focus on data analysis and discovery.
Affordable, Scalable, Smart: The MGI Automation Edge
MGI stands out in the lab automation market by prioritizing cost-effectiveness, scalability, and global accessibility. Designed to democratize advanced technology, MGI empowers researchers across diverse fields—from precision medicine to agriculture—regardless of budget constraints.
MGI provides a comprehensive portfolio that covers the entire workflow, from sample extraction and preparation to sequencing and data analysis. This all-in-one solution enhance chances to meet customers' diversified demand under one system and brand and ensures compatibility among various systems, simplifying the overall experimental workflow.
These advantages have positioned MGI as a trusted partner in more than 100 countries, accelerating breakthroughs in genomics, synthetic biology, and beyond. During global health crises, systems like the Platforms like the MGISP-960 and MGISTP-7000 have processed millions of samples, demonstrating MGI's ability to deliver robust solutions under pressure.
MGI invites researchers, lab managers, and industry professionals to explore its latest automation solutions at SLAS Europe 2025. Visit MGI's booth#516 to see the enhanced innovations in action.
SOURCE MGI TECH
Share this article